Cost‐effectiveness analysis of dinutuximab β for the treatment of high‐risk neuroblastoma in China.

Autor: Shen, An‐Le, Zhao, Jie, Yu, Li‐Ting, Zhang, An‐An, Wu, Bin, Fang, Ye, Han, Ya‐Li, Li, Chen‐Sui‐Zi, Li, Zhi‐Ling, Gao, Yi‐Jin, Zhang, Shun‐Guo
Zdroj: Pediatric Blood & Cancer; Dec2023, Vol. 70 Issue 12, p1-8, 8p
Databáze: Complementary Index
Externí odkaz: